• Profile
Close

LGALS3BP: A potential plasma biomarker associated with diagnosis and prognosis in patients with sepsis

Infection and Drug Resistance Jul 29, 2021

Luo M, Zhang Q, Hu Y, et al. - Through data-independent acquisition (DIA) and enzyme-linked immunosorbent assays (ELISAs), researchers sought to determine differentially expressed proteins (DEPs) in plasma of patients with sepsis. In addition, convenient and accurate serum markers for determining the condition of septic patients were investigated. This study was performed including a total of 53 septic patients and 16 normal controls. They randomly selected 6 specimens from the normal group and 15 from the sepsis group for DIA-based quantitative proteomic analysis. Bioinformatics methods led to the identification of a total of 149 DEPs. The normal and sepsis groups showed significant differences in LGALS3BP levels. Significantly higher levels were evident in septic patients vs normal controls, and in addition, higher levels were observed in non-survivors vs survivors. Its great diagnostic efficacy and prognostic ability in sepsis is suggested by the ROC curves.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay